===================== Product Identification =====================
MSDS NAME:03027 TOBRAMYCIN SULFATE INJECTION 40 MG/ML
NIIN:01-351-9266
MSDS Number: BWXXJ
=== Responsible Party ===
Company:WYETH-AYERST LABORATORIES
Box:8299
City:PHILADELPHIA
State:PA
ZIP:19101-5000
Country:US
Info Phone Num:610-902-5171
Emergency Phone Num:610-902-5171
CAGE:0HMG4
=== Contractor Identification ===
Company:WYETH-AYERST LABORATORIES
Box:City:PHILADELPHIA
State:PA
ZIP:19101-5000
Country:US
Phone:610-902-5171
CAGE:0HMG4
============= Composition/Information on Ingredients =============
Name:TOBRAMYCIN SULFATE *95-1*
CAS:49842-07-1
RTECS #:WK2110000
Fraction by Wt: 4%
Name:TOBRAMYCIN *95-1*
CAS:32986-56-4
RTECS #:WK2100000
Name:SODIUM BISULFITE
CAS:7631-90-5
RTECS #:VZ2000000
Fraction by Wt: 0.3%
OSHA PEL:5 MG/CUM
ACGIH TLV:5 MG/CUM
EPA Rpt Qty:5000 LBS
DOT Rpt Qty:5000 LBS
===================== Hazards Identification =====================
LD50 LC50 Mixture:ORAL LD50 (RAT): >7000 MG/KG (SEE SUPP)
Routes of Entry: Inhalation:YES Skin:YES Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:TOBRAMYCIN-OTOTOXICITY & KIDNEY
TOXICITY, MAY BE ABSORBED IN TOXIC AMOUNTS FROM BODY SURFACES & MAY
CAUSE SYSTEMIC TOXICITY. DAMAGE TO PROXIMAL TUBULE OF NEPHRON MAY
ALSO BE PRODUCED BY AMINOGLYCOSIDE S. AMINOGLYCOSIDES MAY CAUSE
FETAL HARM.
Explanation of Carcinogenicity:NONE
Effects of Overexposure:MILD EYE REDNESS, DIZZINESS, VERTIGO,
RINGING/ROARING IN EARS, HEARING LOSS, ELEVATED BLOOD UREA
NITROGEN/NONPROTEIN NITROGEN/SERUM CREATININE.
Medical Cond Aggravated by Exposure:PRE-EXISTING HYPERSENSITIVITY TO
TOBRAMYCIN/OTHER AMINOGLYCOSIDE ANTIBIOTIC, PRE-EXISTING KIDNEY &
RENAL IMPAIRMENT.
======================= First Aid Measures =======================
Eyes: IMMEDIATELY FLUSH W/PLENTY OF COOL, LOW-PRESSURE WATER
FOR 20 MINS. SKIN: PROMPTLY WASH W/SOAP & COOL RUNNING WATER.
INHALATION: REMOVE TO FRESH AIR. GIVE CPR/OXYGEN IF NEEDED.
INGESTION: DON'T INDUCE VOMITING EXCEPT AS DIRECTED BY MEDICAL
PERSONNEL. DON'T INDUCE VOMITING/GIVE ANYTHING BY MOUTH IF
UNCONSCIOUS. OBTAIN MEDICAL ATTENTION IN ALL CASES.
================== Accidental Release Measures ==================
Spill Release Procedures:WEAR DISPOSABLE COVERALLS, RUBBER GLOVES & AN
APPROVED SELF CONTAINED/SUPPLIED-AIR RESPIRATOR. CONTAIN & COLLECT.
====================== Handling and Storage ======================
Handling and Storage Precautions:STORE AT CONTROLLED ROOM TEMPERATURE,
BETWEEN 59-86F. KEEP CONTAINER CLOSED WHEN NOT IN USE. MINIMIZE
EXCESS HANDLING.
============= Exposure Controls/Personal Protection =============
Respiratory Protection:WEAR AN APPROVED AIR-PURIFYING RESPIRATOR
W/HIGH-EFFICIENCY CARTRIDGES/SUPPLIED-AIR RESPIRATOR WHEN
ENGINEERING CONTROLS AREN'T ADEQUATE TO CONTAIN DUST/MIST.
Ventilation:CLOSED-SYSTEM HANDLING, LABORATORY BENCH HOOD/LOCAL EXHAUST
TO CONTROL DUST/MIST.
Protective Gloves:RUBBER
Eye Protection:RECOMMENDED
Work Hygienic Practices:WASH HANDS & FACE AFTER HANDLING.
REMOVE/LAUNDER CONTAMINATED CLOTHING BEFORE REUSE.
Supplemental Safety and Health
PH: 4.5-5.5. ORAL LD50 INFORMATION IS FOR TOBRAMYCIN SULFATE.
================== Physical/Chemical Properties ==================
pH:(SUPP)
Solubility in Water:COMPLETE
Appearance and Odor:CLEAR, COLORLESS SOLUTION.
================= Stability and Reactivity Data =================
Stability Indicator/Materials to Avoid:YES
Hazardous Decomposition Products:CO/CO2/NITROGEN OXIDES/IRRITATING
ALDEHYDES/KETONES/ORGANIC ACIDS/HYDROGEN CYANIDE/SULFUR
OXIDES/OTHER SULFUR COMPOUNDS.
==================== Disposal Considerations ====================
Waste Disposal Methods:DISPOSE OF IAW/FEDERAL, STATE & LOCAL
REGULATIONS.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
*** END OF RECORD *** |
|
|